Adagene  logo
Adagene ADAG
€ 3.10 -1.37%

Geschäftsbericht 2025
hinzugefügt 25.04.2026

report update icon

Adagene Abschreibung & Amortisation 2011-2026 | ADAG

Abschreibung & Amortisation Jährlich Adagene

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
439 K 723 K 980 K 1.15 M 1.13 M 858 K 817 K 909 K - - - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.15 M 439 K 875 K

Abschreibung & Amortisation anderer Aktien in der Pharmaeinzelhändler

Name Abschreibung & Amortisation Preis % 24h Marktkapitalisierung Land
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
380 K - 1.35 % $ 17.8 M chinaChina
Amphastar Pharmaceuticals Amphastar Pharmaceuticals
AMPH
31.6 M $ 16.88 -2.43 % $ 789 M usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
100 K - -10.17 % $ 12.2 K usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
461 K $ 2.79 -8.09 % $ 261 M israelIsrael
Coherus BioSciences Coherus BioSciences
CHRS
1.3 M $ 1.6 -2.15 % $ 187 M usaUSA
I-Mab I-Mab
IMAB
23.9 M - - $ 866 M chinaChina
AstraZeneca PLC AstraZeneca PLC
AZN
5.73 B - - $ 96.9 B britainBritain
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
3.02 M $ 7.56 -3.45 % $ 207 M israelIsrael
Athira Pharma Athira Pharma
ATHA
972 K - - $ 269 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
20 K - -32.59 % $ 7.61 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
105 K $ 3.13 0.32 % $ 651 M usaUSA
Exelixis Exelixis
EXEL
29.1 M $ 50.41 -1.36 % $ 13.7 B usaUSA
Fortress Biotech Fortress Biotech
FBIO
403 K $ 2.43 5.65 % $ 67.8 M usaUSA
Forte Biosciences Forte Biosciences
FBRX
64 K $ 23.1 -3.57 % $ 299 M usaUSA
AbCellera Biologics AbCellera Biologics
ABCL
18.4 M $ 4.09 -7.05 % $ 1.22 B canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
8.3 M $ 1.59 - $ 423 M britainBritain
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
66 K - - $ 231 M usaUSA
Galectin Therapeutics Galectin Therapeutics
GALT
1 K $ 2.22 -5.74 % $ 142 M usaUSA
Gilead Sciences Gilead Sciences
GILD
370 M $ 130.07 -1.51 % $ 162 B usaUSA
Advaxis Advaxis
ADXS
369 K - -9.65 % $ 45.9 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
24 K $ 3.41 -2.25 % $ 5.61 M israelIsrael
Aeterna Zentaris Aeterna Zentaris
AEZS
58 K - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
744 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.51 M - - $ 26.5 M usaUSA
AIkido Pharma AIkido Pharma
AIKI
105 K - 1.93 % $ 17.4 M usaUSA
Enlivex Therapeutics Ltd. Enlivex Therapeutics Ltd.
ENLV
546 K $ 0.72 -1.05 % $ 32.9 M israelIsrael
Akero Therapeutics Akero Therapeutics
AKRO
18 K - - $ 3.67 B usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
4.04 M $ 29.69 -0.92 % $ 799 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
22 K - -45.71 % $ 1.2 M canadaCanada
Aptinyx Aptinyx
APTX
122 K - -39.0 % $ 4.57 M usaUSA
Akouos Akouos
AKUS
2.49 M - 0.23 % $ 488 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
274 K - -0.23 % $ 916 M usaUSA
AlloVir AlloVir
ALVR
13 K - 4.14 % $ 49.1 M usaUSA
Allakos Allakos
ALLK
6.14 M - - $ 28.6 M usaUSA
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
700 K $ 21.51 -0.3 % $ 2.74 B usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
363 K - 3.16 % $ 1.9 M usaUSA